Time schedule: The recruitment phase will run over a period of 12 months. Enrolled participants will be treated for 6 months. First patient first visit (FPFV) is planned for January 2017 and the last patient last visit (LPLV) is expected in June 2018. The overall end of trial time point is defined as LPLV.